Aligos Therapeutics Inc (NASDAQ:ALGS)

1.11
Delayed Data
As of Mar 27
 -0.02 / -1.77%
Today’s Change
0.84
Today|||52-Week Range
2.41
+16.49%
Year-to-Date
No recent news for Aligos Therapeutics Inc.

Today’s Trading

Previous close1.13
Today’s open1.08
Day’s range1.08 - 1.11
Volume572
Average volume (3 months)314,117
Market cap$47.7M
Data as of 3:42pm ET, 03/27/2023

Growth & Valuation

Earnings growth (last year)+30.13%
Earnings growth (this year)+29.63%
Earnings growth (next 5 years)--
Revenue growth (last year)+219.04%
P/E ratioNM
Price/Sales2.93
Price/Book0.45

Competitors

No competitors data available.

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$13.9M
Annual profit (last year)-$96.0M
Net profit margin-690.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts